TB and antiretroviral treatment in Thyolo district, Malawi Southern

Download Report

Transcript TB and antiretroviral treatment in Thyolo district, Malawi Southern

Antiretroviral treatment programme in
Thyolo district, Malawi Southern Region.
MSF Luxembourg &
Thyolo District Health Services
- Strategic information used for preparation
- Monitoring & Evaluation
- Challenges to overcome
Dr. Roger Teck – July 1st, 2003
HIV/AIDS in Thyolo District




Mainly rural population: 475,000 people
Prevalence level of HIV infection among pregnant
mothers: around 21%
People living wih HIV/AIDS: about 50,000
People with AIDS: 5,000 – 10,000 ?
HIV Continuum of Care in Thyolo district
(June, 2003)




7 VCT sites and one PMTCT site:
- 1,300 – 1,500 tested monthly
- 35 – 40 % test HIV +
Close to 2,300 a-symptomatic and symptomatic
HIV+ patients supported through HBC and health
centres.
Access for TB patients (1,200 per year) to VCT (>
90 % uptake, > 70 % HIV+) and CTX prophylaxis.
1,700 symptomatic HIV + patients registered at
district hospital based HIV/AIDS clinic
Strategic information (1)

Institutional back-up

Perspectives for sustainable financing
-
Through MSF
Global Fund
Other mechanisms
Strategic information (2)

Policy environment allowing importation of
generic ARV medicines

Elaboration of draft Malawi ART guidelines
- Organisational framework
- Objectives & targets (Global Fund proposal)
- Input and output indicators
- Eligibility criteria.
- First line treatment regimens
- Clinical guidance for drug toxicity & treatment failure
- Monitoring & evaluation framework
Strategic information (3)

Estimates on the burden of HIV infection and
AIDS

Assessment of health facilities
- District hospital and 9 health centres
- Missionary hospital and 8 health centres

Community
- Perception of HIV/AIDS and HIV/AIDS/TB services
- Expectations on ART treatment.
Main target and strategies for “scaling up”
of the ART programme

Over five years
period:
access to
HAART for
at least 50 % of
people with AIDS







Simplified clinical protocol
Fixed drug combination
With national staff
Screening & preparation in
HBC and PMTCT population
Two HIV/ART clinics (two
hospitals)
Decentralisation through
health centres
Adherence follow-up
through guardians and HBC
Organisational plan for HIV/ART clinic

Infrastructure and staffing for the HIV/AIDS clinic
to manage “in addition” a maximum of 700
patients during first 6 months of treatment:
- One receptionist
- Two “consultation units” (one clinical officer + nurse)
- Two “ART units” with each one nurse counsellor
- Patient archive and data base: data entry technician
(supported by one expatriate medical doctor)


Patient flow: quick and slow circuit
Week programme
Patient follow-up
timing
Group
session
-7 days
X
CounselClinical Parallel
ling, weight consult. laboratory
monitoring
& ART
X
Day 1
X
X
X
14 days
X
X
X
14 days
X
X
X
Every 28
days
X
6 Months
X
X
X
Programme Monitoring & Evaluation (1)
according to Malawi treatment guidelines



Outcome Indicators of Global Fund targets
Similar to NTP M&E system
Paper- based
- patient identity card/stamp (“health passport”)
- patient master card (file) for registration of monthly
treatment outcome, “functional” status, side
effects and adherence
- quarterly cohort analysis forms
- drug security form
Programme Monitoring & Evaluation (2)
“Fuchsia” Software Electronic Data base

Epicentre and Mèdecins sans Fontieres

Monthly & cumulative reporting on:
- HIV clinic
- ART programme

Patient summaries
Antiretroviral treatment programme update
April 22nd - June 27th.
Total on ART
103
Stage III
55
Stage IV
43
Children
5
Deaths
2
Serious side
effects
2
Strategic information and monitoring &
evaluation: challenges



WHO staging
Decentralisation to health centres:
- Continuation of follow-up of ART for children
- Drug security
- Staff capacity
- Monitoring & evaluation
Linking to other treatment centres
- Transfers
- ART “shopping”